Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma
Rafee Talukder, Dimitra Rafailia Bakaloudi, Dimitrios Makrakis, Leonidas N Diamantopoulos, Thomas Enright, Jacob B Leary, Ruben Raychaudhuri, Nishita Tripathi, Neeraj Agarwal, Tanya Jindal, Jason R Brown, Yousef Zakharia, Macarena Rey-Cárdenas, Daniel Castellano, Charles B Nguyen, Ajjai Alva, Roubini Zakopoulou, Aristotelis Bamias, Rafael Morales Barrera, David MarmolejoAlexandra Drakaki, David James PINATO, James Korolewicz, Lucia Alonso Buznego, Ignacio Duran, Clara Castro Carballeira, Rana R McKay, Tyler F Stewart, Shilpa Gupta, Pedro Barata, Evan Y Yu, Vadim S Koshkin, Ali Raza Khaki, Petros Grivas
Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review
Fingerprint
Entra nei temi di ricerca di 'Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma'. Insieme formano una fingerprint unica.